IGF2BP3 loss inhibits cell progression by upregulating has_circRNA_103820, and hsa_circRNA_103820‐encoded peptide inhibits cell progression by inactivating the AKT pathway in lung cancer
Chemical Biology & Drug Design · 2024-02 · 103 (2)
DOI: 10.1111/cbdd.14473 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 20.02.2024. Verfasst von Jinrong Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, People's Hospital of Dongxihu District, Wuhan, China. Hauptthemen laut MEDLINE: MicroRNAs, Lung Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: The Wuhan Medical Research Project of Hubei Province (No. WX20B18).
Abstract (Originalsprache)
N6‐methyladenosine (m6A) modification and m6A‐related RNA‐binding proteins (RBPs) play vital roles in various aspects of circRNA metabolism. Hsa_circRNA_103820 is implicated in the pathogenesis of multiple cancers, including lung cancer (LC). Moreover, bioinformatics analysis has suggested that hsa_circRNA_103820 possesses potential peptide‐coding ability. Thus, we aimed to investigate the function and peptide‐coding potential of hsa_circRNA_103820 in this study. Cell viability, apoptosis rate, and migratory and invasive abilities were assessed using CCK‐8, flow cytometry, and transwell assays, respectively. Hsa_circRNA_103820 level was measured using RT‐qPCR assay, and the interaction between hsa_circRNA_103820 and IGF2BP3 was examined through RIP and RT‐qPCR assays. The coding ability of hsa_circRNA_103820 and protein levels were determined through western blot assay. The results showed that hsa_circRNA_103820 reduced cell viability, attenuated cell migratory and invasive abilities, and promoted cell apoptosis in LC. IGF2BP3 negatively regulated hsa_circRNA_103820 expression and interacted with it. Hsa_circRNA_103820 knockdown alleviated si‐IGF2BP3‐mediated anti‐viability, anti‐migration, anti‐invasion, and pro‐apoptosis effects in LC cells. Moreover, a 188‐amino acid (aa) peptide encoded by hsa_circRNA_103820 decreased cell viability, facilitated cell apoptosis, and inhibited cell migration and invasion in LC. Collectively, hsa_circRNA_103820, regulated by IGF2BP3, encodes a 188‐aa peptide and inhibits the malignant progression of LC cells by inhibiting the AKT pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, People's Hospital of Dongxihu District, Wuhan, China.
- Department of Respiratory and Critical Care Medicine, Union Hospital affiliated to Huazhong University of Science and Technology, Wuhan, China.
- Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of China Medical University, Shenyang, China.
Förderung
- The Wuhan Medical Research Project of Hubei Province (No. WX20B18)
Zitieren
APA
Zhou, J., Yao, L., Su, Y., & Tian, L. (2024). IGF2BP3 loss inhibits cell progression by upregulating has_circRNA_103820, and hsa_circRNA_103820‐encoded peptide inhibits cell progression by inactivating the AKT pathway in lung cancer. Chemical Biology & Drug Design, 103(2). https://doi.org/10.1111/cbdd.14473
Vancouver
Zhou J, Yao L, Su Y, Tian L. IGF2BP3 loss inhibits cell progression by upregulating has_circRNA_103820, and hsa_circRNA_103820‐encoded peptide inhibits cell progression by inactivating the AKT pathway in lung cancer. Chemical Biology & Drug Design. 2024;103(2). doi:10.1111/cbdd.14473
BibTeX
@article{Zhou2024,
author = {Zhou, Jinrong and Yao, Lixia and Su, Yuan and Tian, Lili},
title = {IGF2BP3 loss inhibits cell progression by upregulating has_circRNA_103820, and hsa_circRNA_103820‐encoded peptide inhibits cell progression by inactivating the AKT pathway in lung cancer},
journal = {Chemical Biology & Drug Design},
year = {2024},
volume = {103},
number = {2},
doi = {10.1111/cbdd.14473}
}
EUVIMED